U.S., Feb. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07414147) titled 'TMS for Improving Cognitive Function in Bipolar Disorder' on Jan. 13.
Brief Summary: Bipolar disorder is a highly disabling psychiatric illness, and cognitive impairment is common in patients with bipolar depression as well as during remission, contributing substantially to functional disability and poorer prognosis. Currently, effective interventions specifically targeting cognitive deficits remain limited, highlighting the need for novel treatment strategies. Transcranial magnetic stimulation, a noninvasive neuromodulation technique, has shown potential benefits for depressive symptoms and cognitive functioning. Based on structura...